Companies
Optimi Health
Natural psilocybin + functional mushrooms — Health Canada Dealer's Licence, GMP.
- Country
- Canada
us
licensed
gmp
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Approximately CAD$30M raised since founding; CAD$20.7M gross proceeds from 2026 public offering | ir.optimi.net · sec.gov |
| Capacity | Capacity to manufacture millions of doses for export; facility vault capable of securing 1,250 kg of psilocybin | financialpost.com · ir.optimi.net · sedar-filings-primary.thecse.com |
| Certification | GMP (Good Manufacturing Practices) certified | ir.optimi.net · sedar-filings-primary.thecse.com · synapse.patsnap.com · prnewswire.com |
| Regulatory approval | Health Canada Drug Establishment Licence (DEL) and Dealer’s Licence; FDA Establishment Identifier (FEI) obtained in 2025 | financialpost.com · ir.optimi.net · sedar-filings-primary.thecse.com · prnewswire.com |
| Production site | Two purpose-built facilities totaling 20,000 sq. ft. in Princeton, British Columbia | financialpost.com · ir.optimi.net · sedar-filings-primary.thecse.com · synapse.patsnap.com · prnewswire.com |
| Revenue | CAD$239,700 for the nine-month period ended June 30, 2026 | sec.gov |
Independent sources: financialpost.com · ir.optimi.net · prnewswire.com · sec.gov · sedar-filings-primary.thecse.com · synapse.patsnap.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Adaptogens and legal entheogens (nutraceutical market) | food-alt-protein | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.